Pitfalls of anesthetic management with the Impella® 5.0 device: a case series

Abstract Background Impella® is an antegrade left ventricular assist device with a pump catheter in the left ventricle. We report three cases in which we experienced some pitfalls with circulatory management during Impella placement due to new-onset aortic insufficiency (AI) associated with device p...

Full description

Bibliographic Details
Main Authors: Naoshi Hotta, Akito Tsukinaga, Kenji Yoshitani, Yoshihiko Ohnishi
Format: Article
Language:English
Published: SpringerOpen 2020-03-01
Series:JA Clinical Reports
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40981-020-00324-9
id doaj-f772aff2c5664f9ea411a57b19efe2d7
record_format Article
spelling doaj-f772aff2c5664f9ea411a57b19efe2d72021-04-02T11:48:17ZengSpringerOpenJA Clinical Reports2363-90242020-03-01611510.1186/s40981-020-00324-9Pitfalls of anesthetic management with the Impella® 5.0 device: a case seriesNaoshi Hotta0Akito Tsukinaga1Kenji Yoshitani2Yoshihiko Ohnishi3Department of Anesthesiology, National Cerebral and Cardiovascular CenterDepartment of Anesthesiology, National Cerebral and Cardiovascular CenterDepartment of Anesthesiology, National Cerebral and Cardiovascular CenterDepartment of Anesthesiology, National Cerebral and Cardiovascular CenterAbstract Background Impella® is an antegrade left ventricular assist device with a pump catheter in the left ventricle. We report three cases in which we experienced some pitfalls with circulatory management during Impella placement due to new-onset aortic insufficiency (AI) associated with device placement or the limited maximum flow rate. Case presentation Three patients developed new-onset AI due to Impella placement. In a patient, the total assisted flow rate was relatively low because of his large body size. In the other patients, in whom the Impella device was used in combination with percutaneous cardiopulmonary support or venoarterial extracorporeal membrane oxygenation (ECMELLA), total flow was maintained at a sufficient level. Conclusions New-onset of AI after Impella placement and its limited flow rate are considered to be pitfalls in circulatory management. Management with ECMELLA is considered to be effective during the acute phase when patients have decreased cardiac function.http://link.springer.com/article/10.1186/s40981-020-00324-9Percutaneous ventricular assist deviceAdvanced medical careHeart failure
collection DOAJ
language English
format Article
sources DOAJ
author Naoshi Hotta
Akito Tsukinaga
Kenji Yoshitani
Yoshihiko Ohnishi
spellingShingle Naoshi Hotta
Akito Tsukinaga
Kenji Yoshitani
Yoshihiko Ohnishi
Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
JA Clinical Reports
Percutaneous ventricular assist device
Advanced medical care
Heart failure
author_facet Naoshi Hotta
Akito Tsukinaga
Kenji Yoshitani
Yoshihiko Ohnishi
author_sort Naoshi Hotta
title Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
title_short Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
title_full Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
title_fullStr Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
title_full_unstemmed Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
title_sort pitfalls of anesthetic management with the impella® 5.0 device: a case series
publisher SpringerOpen
series JA Clinical Reports
issn 2363-9024
publishDate 2020-03-01
description Abstract Background Impella® is an antegrade left ventricular assist device with a pump catheter in the left ventricle. We report three cases in which we experienced some pitfalls with circulatory management during Impella placement due to new-onset aortic insufficiency (AI) associated with device placement or the limited maximum flow rate. Case presentation Three patients developed new-onset AI due to Impella placement. In a patient, the total assisted flow rate was relatively low because of his large body size. In the other patients, in whom the Impella device was used in combination with percutaneous cardiopulmonary support or venoarterial extracorporeal membrane oxygenation (ECMELLA), total flow was maintained at a sufficient level. Conclusions New-onset of AI after Impella placement and its limited flow rate are considered to be pitfalls in circulatory management. Management with ECMELLA is considered to be effective during the acute phase when patients have decreased cardiac function.
topic Percutaneous ventricular assist device
Advanced medical care
Heart failure
url http://link.springer.com/article/10.1186/s40981-020-00324-9
work_keys_str_mv AT naoshihotta pitfallsofanestheticmanagementwiththeimpella50deviceacaseseries
AT akitotsukinaga pitfallsofanestheticmanagementwiththeimpella50deviceacaseseries
AT kenjiyoshitani pitfallsofanestheticmanagementwiththeimpella50deviceacaseseries
AT yoshihikoohnishi pitfallsofanestheticmanagementwiththeimpella50deviceacaseseries
_version_ 1721571246618968064